More importantly, iIn the DIABHYCAR study (n = 3101 patients with T2DM and albuminuria) and in the SURDIAGENE cohort (n = 1407 patients with T2DM), plasma copeptin levels were associated with increased risk of cardiovascular events during a median follow-up of 5 years [61]. The gene discussed is AVP; the disease is type 2 diabetes mellitus.